}

Hospira recalls Hydromorphone injection

03/26/2018

Hospira is voluntarily recalling three lots of Hydromorphone HCl Injection, USP CII 10 mg/mL, 1 mL in 2 mL Single Dose Vials due to the potential that units from these lots may be empty or cracked at the bottom of the glass vial. Cracked vials may compromise product sterility. Read the FDA safety alert.

<< return to Advocacy Updates